Center for Molecular Toxicology and Carcinogenesis, Department of Veterinary and Biomedical Sciences, Penn State University, University Park, Pennsylvania 16802, USA.
Toxicol Sci. 2011 Oct;123(2):550-62. doi: 10.1093/toxsci/kfr191. Epub 2011 Jul 21.
The constitutive androstane receptor (CAR; NR1I3) is a member of the nuclear receptor superfamily and functions as an important xenochemical sensor and transcriptional modulator in mammalian cells. Upon chemical activation, CAR undergoes nuclear translocation and heterodimerization with the retinoid X receptor subsequent to its DNA target interaction. CAR is unusual among nuclear receptors in that it possesses a high level of constitutive activity in cell-based assays, obscuring the detection of ligand activators. However, a human splice variant of CAR, termed CAR3, exhibits negligible constitutive activity. In addition, CAR3 is activated by ligands with similar specificity as the reference form of the receptor. In this study, we hypothesized that similar CAR3 receptors could be constructed across various mammalian species' forms of CAR that would preserve species-specific ligand responses, thus enabling a more sensitive and differential screening assessment of CAR response among animal models. A battery of CAR3 receptors was produced in mouse, rat, and dog and comparatively evaluated with selected ligands together with human CAR1 and CAR3 in mammalian cell reporter assays. The results demonstrate that the 5-amino acid insertion that typifies human CAR3 also imparts ligand-activated receptor function in other species' CAR while maintaining signature responses in each species to select CAR ligands. These variant constructs permit in vitro evaluation of differential chemical effector responses across species and coupled with in vivo assays, the species-selective contributions of CAR in normal physiology and in disease processes such as hepatocarcinogenesis.
组成型雄烷受体 (CAR; NR1I3) 是核受体超家族的成员,作为哺乳动物细胞中重要的外源性化学物质传感器和转录调节剂发挥作用。在化学激活后,CAR 经历核易位,并与视黄酸 X 受体形成异二聚体,随后与 DNA 靶标相互作用。CAR 在核受体中是不寻常的,因为它在基于细胞的测定中具有高水平的组成活性,从而掩盖了对配体激活剂的检测。然而,CAR 的一种人类剪接变体,称为 CAR3,表现出可忽略不计的组成活性。此外,CAR3 被与受体参考形式具有相似特异性的配体激活。在这项研究中,我们假设可以在各种哺乳动物形式的 CAR 上构建类似的 CAR3 受体,从而保留物种特异性的配体反应,从而能够更敏感和差异化地筛选动物模型中的 CAR 反应。在哺乳动物细胞报告基因测定中,我们制备了一系列小鼠、大鼠和犬的 CAR3 受体,并与选定的配体一起对其进行了比较评估,同时还评估了人类 CAR1 和 CAR3。结果表明,典型的人类 CAR3 的 5 个氨基酸插入也赋予了其他物种 CAR 的配体激活受体功能,同时保持了每种物种对特定 CAR 配体的特征反应。这些变体构建体允许在体外评估跨物种的化学效应物反应差异,并与体内测定相结合,评估 CAR 在正常生理和疾病过程(如肝癌发生)中的物种选择性贡献。